A combination of government policies and market trends is causing significant turmoil in the Prescription Drug Plan (PDP) market, especially for plans that serve beneficiaries who receive the Medicare ...
Medicare beneficiaries who qualify for the Medicare Low-Income Subsidy Program could be eligible this year to pay no more than $2.50 for generic drugs and $6.30 for brand name drugs, according to a ...
Patients with cancer who participated in the Medicare Low-Income Subsidy program were less likely to receive any systemic cancer therapy compared with patients not participating in the program. Among ...
A total of 14 million Medicare beneficiaries receive the Low-Income Subsidy (LIS), which reduces cost sharing in Medicare Part D. Losing the LIS may impede medication access and affect mortality.